2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 16:32 (3871 d 20:26 ago) – Posting: # 11336
Views: 40,201

Hi HS

❝ Followed by:

❝ If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.

❝ … provided that the group meets minimum requirements for a complete bioequivalence study.


According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
120 visitors (0 registered, 120 guests [including 10 identified bots]).
Forum time: 11:58 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5